<p>Francis Delpeyroux of the Institut Pasteur in France will research whether adding immune pressure against proteins found in the attenuated strains of the oral polio vaccine could lead to the emergence of recombinant circulating vaccine-derived polioviruses. Identifying this mechanism could help in development of better vaccines to control polio outbreaks.</p>


Francis Delpeyroux of the Institut Pasteur in France will research whether adding immune pressure against proteins found in the attenuated strains of the oral polio vaccine could lead to the emergence of recombinant circulating vaccine-derived polioviruses. Identifying this mechanism could help in development of better vaccines to control polio outbreaks.